Every Instrument Has an ID Now: How UDI Direct Marking Is Turning Surgical Instrument Sourcing into a Data Decision

Ask a sterile processing manager about their biggest daily headache and the answer is rarely the autoclave. It’s the tray that comes up one instrument short, the specialty clamp nobody can find, or the set that gets flash-processed because its twin is still sitting in a decontamination sink across the building. Those small failures delay first cases, frustrate surgeons and quietly drive up instrument spend.

For most of the last century, a hemostat was a hemostat. Hospitals tracked instruments by the set, not by the piece, and buying decisions came down to price, feel and the surgeon’s preferred brand. That is changing. Regulators in the United States and Europe now expect reusable surgical instruments to carry a permanent unique device identifier, and software that reads those marks is becoming a normal part of sterile processing. The result is that sourcing a pair of scissors is no longer just a purchasing decision. It is also a data decision.

This article looks at what the regulations require, how instrument-level tracking works in practice, and what supply chain and perioperative leaders should now ask of the manufacturers who make their instruments.

What the rules actually require

The idea behind unique device identification (UDI) is simple: every medical device should carry a standard code that identifies the device model and, where relevant, its production details, so it can be traced through recalls, adverse event reports and inventory systems.

For reusable devices, a label on the packaging is not enough, because the packaging is thrown away after the first use. So both major regulators require the identifier to be marked directly on the device itself, in a form that lasts for the device’s working life.

Most manual surgical instruments, such as scissors, forceps, needle holders and retractors, are Class I devices. In the US, some Class I devices are exempt from UDI requirements, so manufacturers and buyers should confirm the status of each product rather than assume. In the EU, reusable surgical instruments sit in their own subcategory, often written as Class Ir. They need a notified body to review the manufacturer’s cleaning, sterilization and reuse instructions, which is a step up from the self-declaration that covers most other Class I products.

The EU deadline is the one many teams are watching now. Instruments placed on the European market under the MDR will need a direct UDI mark from May 2027, and hospitals that buy for both US and EU sites increasingly want the same marking standard across their whole inventory.

How instrument-level tracking works

On the instrument itself, the identifier is usually a small two-dimensional Data Matrix code, laser-marked or dot-peened into a flat area of the shank or handle. Laser marking is the most common method because it does not add material and, done correctly, does not disturb the steel’s corrosion-resistant surface. The code has to survive hundreds of cycles of washing, ultrasonic cleaning and steam sterilization and still be readable.

In sterile processing, technicians scan each instrument as they assemble a tray. The tracking software checks it against the tray’s count sheet, flags anything missing or wrong, and logs which instruments went into which set, which sterilizer load they went through and, eventually, which patient they were used on. Over time that builds a usage history for every individual instrument.

That history is where the real value lies. With piece-level data, a hospital can answer questions that used to be guesswork:

• Which instruments in a set are never actually used, and can be pulled to make trays lighter and faster to process?
• Which brands or suppliers go out for repair most often, and after how many cycles?
• Where do instruments go missing, and how many are being replaced each year because of loss rather than wear?
• If a supplier issues a recall or a batch turns out to be defective, exactly which trays, and which patients, are affected?

Radio-frequency (RFID) tags are also used for instruments, but heat, moisture and the size of the tag make them harder to apply to small steel instruments. For most facilities, an engraved two-dimensional code read by a camera scanner is the practical choice.

Why this changes how instruments are bought

Once every instrument carries an ID and every cycle is logged, the true cost of an instrument becomes visible. The purchase price stops being the main number. What matters is cost per use: the price, plus repairs, plus replacements, divided by the number of cases the instrument actually supports before it is retired.

Tracking data tends to expose two uncomfortable truths. Cheap instruments that look like a saving often show up again and again in repair logs. And premium-branded instruments are not always better, because many are made by the same contract manufacturers who also sell under their own names.

That second point matters more than many buyers realize. A large share of the world’s reusable stainless steel instruments are forged and finished in Sialkot, a city in Pakistan’s Punjab province that has specialized in the trade since the colonial era. Its workshops produce more than 10,000 different instruments, much of it on an original equipment manufacturer (OEM) basis for European and American brands. Surgical instrument exports from Pakistan were roughly $445 million in 2025, according to the country’s surgical manufacturers’ association.

For health systems with good tracking data, this opens a practical option: working directly with qualified surgical instruments manufacturers in Pakistan, and using their own repair and cycle data to check that the instruments perform as well as the branded versions they replace. Without tracking data, that kind of switch is a leap of faith. With it, it becomes a measurable pilot.

What to ask a manufacturer now

Whether a supplier is a global brand or a direct manufacturer, the questions are the same. A credible partner should be able to answer all of them in writing.

A surgical instruments supplier from Pakistan that already serves European OEM customers will often have these answers ready, because those customers have been asking for them since the MDR took effect. That is a useful signal in itself: a supplier that can document its marking, materials and regulatory status is usually one that can deliver consistent quality.

A practical way to start

Few hospitals can re-mark and re-source an entire instrument inventory at once. A phased approach works better:

1. Start with your data. If you already track at the tray level, pull repair and replacement history to find the instrument types that cost the most over their lifetime.
2. Mark what you keep. Many existing instruments can be laser-marked by service providers, bringing older inventory into the tracking system.
3. Pilot new sources on a few high-use items. Choose instrument types with clear performance measures, such as needle holders or general-purpose scissors, and run new suppliers’ instruments alongside current stock.
4. Compare cost per use, not unit price. After several months, compare repair rates, rejection rates at inspection and surgeon feedback.
5. Write marking requirements into contracts. New purchase agreements should specify UDI direct marking, data format and durability, so every new instrument arrives ready for tracking.

The bottom line

UDI direct marking began as a regulatory requirement, but its real value is operational. Once instruments carry a permanent, readable identity, hospitals can see how each one performs, what it really costs and where it goes. That visibility rewards buyers who look past brand names to the manufacturers behind them, and it rewards manufacturers who can prove their quality with data rather than claims. For perioperative and supply chain leaders, the instrument tray has quietly become one more place where good data drives better decisions.